問卷

TPIDB > Search Result > Clinical Trials List

Clinical Trials List

Protocol NumberCHK02-02
Active

2023-12-01 - 2029-06-30

Phase III

Not yet recruiting8

ICD-10N05.0

Unspecified nephritic syndrome with minor glomerular abnormality

ICD-10N05.1

Unspecified nephritic syndrome with focal and segmental glomerular lesions

ICD-10N05.6

Unspecified nephritic syndrome with dense deposit disease

ICD-10N05.7

Unspecified nephritic syndrome with diffuse crescentic glomerulonephritis

ICD-10N05.8

Unspecified nephritic syndrome with other morphologic changes

ICD-10N06.0

Isolated proteinuria with minor glomerular abnormality

ICD-10N06.1

Isolated proteinuria with focal and segmental glomerular lesions

ICD-10N06.6

Isolated proteinuria with dense deposit disease

ICD-10N06.7

Isolated proteinuria with diffuse crescentic glomerulonephritis

ICD-10N06.8

Isolated proteinuria with other morphologic lesion

ICD-10N07.0

Hereditary nephropathy, not elsewhere classified with minor glomerular abnormality

ICD-10N07.1

Hereditary nephropathy, not elsewhere classified with focal and segmental glomerular lesions

ICD-10N07.6

Hereditary nephropathy, not elsewhere classified with dense deposit disease

ICD-10N07.7

Hereditary nephropathy, not elsewhere classified with diffuse crescentic glomerulonephritis

ICD-10N07.8

Hereditary nephropathy, not elsewhere classified with other morphologic lesions

ICD-10N14.0

Analgesic nephropathy

ICD-10N14.1

Nephropathy induced by other drugs, medicaments and biological substances

ICD-10N14.2

Nephropathy induced by unspecified drug, medicament or biological substance

ICD-10N14.3

Nephropathy induced by heavy metals

ICD-10N14.4

Toxic nephropathy, not elsewhere classified

ICD-10N15.0

Balkan nephropathy

ICD-10N15.8

Other specified renal tubulo-interstitial diseases

ICD-9583.89

Nephritis and nephropathy, not specified as acute or chronic, with other specified pathological lesion in kidney

  • Sponsor

  • Trial scale

    Multi-Regional Multi-Center

  • Update

    2026/04/01

Investigators and Locations

Principal Investigator 徐邦治 Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Chien-Hsing Wu Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Heng-Chih Pan Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator 吳家麟 Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Junne-Ming Sung Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator VIN-CENT Wu Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator 楊忠煒 Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Principal Investigator Chung-Yi Cheng Division of Nephrology

Co-Principal Investigator

The Actual Total Number of Participants Enrolled

0 Not yet recruiting

Condition/Disease

Objectives

Test Drug

Active Ingredient

Dosage Form

Dosage

Endpoints

Inclution Criteria

The Estimated Number of Participants

  • Taiwan

    14 participants

  • Global

    292 participants